---
figid: PMC5488057__cvja-28-127-g001
figtitle: Conceptual model of general health factors, salient CHD pathogenetic pathways
  and CHD hallmarks
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5488057
filename: cvja-28-127-g001.jpg
figlink: /pmc/articles/PMC5488057/figure/F1/
number: F1
caption: 'Conceptual model of general health factors, salient CHD pathogenetic pathways
  and CHD hallmarks. (From: M Mathews, L Liebenberg, E Mathews. How do high glycemic
  load diets influence coronary heart disease? Nutr Metab 2015; 12(1): 6.7) The affective
  pathway of pharmacotherapeutics (blue boxes) is shown in Fig. 1, and salient serological
  biomarkers are indicated by the tags ( ). The blunted arrows denote antagonise or
  inhibit, and pointed arrows denote up-regulate or facilitate. ACE, angiotensin converting
  enzyme; BDNF, brain-derived neurotrophic factor; β-blocker, beta-adrenergic antagonists;
  BNP, B-type natriuretic peptide; COX, cyclooxygenase; CRP, C-reactive protein; D-dimer,
  fibrin degradation product D; FFA, free fatty acids; GCF, gingival crevicular fluid;
  HbA1c, glycosylated haemoglobin A1c; HDL, high-density lipoprotein; Hs, homocysteine;
  ICAM, intracellular adhesion molecule; IGF-1, insulin-like growth factor-1; IL,
  interleukin; LDL, low-density lipoprotein; MAPK, mitogen-activated protein (MAP)
  kinase; MCP, monocyte chemo-attractant protein; MIF, macrophage migration inhibitory
  factor; MMP, matrix metalloproteinase; MPO, myeloperoxidase; NFκβ, nuclear factor-κβ;
  NLRP3, Inflammasome responsible for activation of inflammatory processes as well
  as epithelial cell regeneration and microflora; NO, nitric oxide; NO-NSAIDs, combinational
  NO-non-steroidal anti-inflammatory drug; OPG, osteoprotegerin; oxLDL, oxidised LDL;
  PAI, plasminogen activator inhibitor; PDGF, platelet-derived growth factor; P gingivalis,
  Porphyromonas gingivalis; PI3K, phosphatidylinositol 3-kinase; RANKL, receptor activator
  of nuclear factor kappa-beta ligand; ROS, reactive oxygen species; SCD-40, recombinant
  human sCD40 ligand; SMC, smooth muscle cell; SSRI, serotonin reuptake inhibitors;
  TF, tissue factor; TMAO, an oxidation product of trimethylamine (TMA); TNF-α , tumour
  necrosis factor-α; VCAM, vascular cell adhesion molecule; vWF, von Willebrand factor.'
papertitle: The integrated effect of moderate exercise on coronary heart disease.
reftext: Marc J Mathews,, et al. Cardiovasc J Afr. 2017 Mar-Apr;28(2):125-133.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9272202
figid_alias: PMC5488057__F1
figtype: Figure
redirect_from: /figures/PMC5488057__F1
ndex: 169e1338-deb0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5488057__cvja-28-127-g001.html
  '@type': Dataset
  description: 'Conceptual model of general health factors, salient CHD pathogenetic
    pathways and CHD hallmarks. (From: M Mathews, L Liebenberg, E Mathews. How do
    high glycemic load diets influence coronary heart disease? Nutr Metab 2015; 12(1):
    6.7) The affective pathway of pharmacotherapeutics (blue boxes) is shown in Fig.
    1, and salient serological biomarkers are indicated by the tags ( ). The blunted
    arrows denote antagonise or inhibit, and pointed arrows denote up-regulate or
    facilitate. ACE, angiotensin converting enzyme; BDNF, brain-derived neurotrophic
    factor; β-blocker, beta-adrenergic antagonists; BNP, B-type natriuretic peptide;
    COX, cyclooxygenase; CRP, C-reactive protein; D-dimer, fibrin degradation product
    D; FFA, free fatty acids; GCF, gingival crevicular fluid; HbA1c, glycosylated
    haemoglobin A1c; HDL, high-density lipoprotein; Hs, homocysteine; ICAM, intracellular
    adhesion molecule; IGF-1, insulin-like growth factor-1; IL, interleukin; LDL,
    low-density lipoprotein; MAPK, mitogen-activated protein (MAP) kinase; MCP, monocyte
    chemo-attractant protein; MIF, macrophage migration inhibitory factor; MMP, matrix
    metalloproteinase; MPO, myeloperoxidase; NFκβ, nuclear factor-κβ; NLRP3, Inflammasome
    responsible for activation of inflammatory processes as well as epithelial cell
    regeneration and microflora; NO, nitric oxide; NO-NSAIDs, combinational NO-non-steroidal
    anti-inflammatory drug; OPG, osteoprotegerin; oxLDL, oxidised LDL; PAI, plasminogen
    activator inhibitor; PDGF, platelet-derived growth factor; P gingivalis, Porphyromonas
    gingivalis; PI3K, phosphatidylinositol 3-kinase; RANKL, receptor activator of
    nuclear factor kappa-beta ligand; ROS, reactive oxygen species; SCD-40, recombinant
    human sCD40 ligand; SMC, smooth muscle cell; SSRI, serotonin reuptake inhibitors;
    TF, tissue factor; TMAO, an oxidation product of trimethylamine (TMA); TNF-α ,
    tumour necrosis factor-α; VCAM, vascular cell adhesion molecule; vWF, von Willebrand
    factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Orai
  - de
  - egr
  - pra
  - prg
  - aop
  - tha
  - MKP-4
  - p38b
  - rl
  - sel
  - sei
  - Mf
  - betaTub60D
  - pi
  - Orc1
  - fru
  - se
  - snRNP-U1-C
  - COX1
  - Rtnl2
  - aa
  - TNF
  - LOXL1
  - S100A6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - SELE
  - SELL
  - SELP
  - VCAM1
  - ICAM1
  - ICAM2
  - ICAM3
  - ICAM4
  - ICAM5
  - DYNLL1
  - SAT1
  - DYM
  - PTGS1
  - SCD5
  - MPO
  - IGF1
  - Choline
  - Serotonin
---
